WESTON (dpa-AFX) - Biogen Idec (BIIB) said two new dosing innovations designed to help patients receiving once-a-week AVONEX for relapsing forms of multiple sclerosis, or MS, are now available in U.S. pharmacies.
The new AVONEX PEN is the first intramuscular autoinjector for chronic use, designed to enhance the self-injection process for patients receiving AVONEX therapy. The company noted that a new dose titration regimen, facilitated by the AVOSTARTGRIP titration devices, provides patients with the option to gradually increase the dose of AVONEX at treatment initiation to reduce the incidence and severity of flu-like symptoms that patients may experience with therapy.
These product enhancements offer the potential for a more tolerable initiation and an easier injection process compared to the AVONEX Prefilled Syringe.
AVONEX PEN is available from the same pharmacies patients currently fill their AVONEX Prefilled Syringe prescriptions.
Copyright RTT News/dpa-AFX
© 2012 AFX News
